McKesson (MCK) Reports Strong Fiscal 2024 Results and Promising Outlook for 2025

Wednesday, 8 May 2024, 00:45

McKesson delivered solid performance in fiscal 2024, exceeding expectations with consolidated revenue growth of 12% to $309 billion and adjusted earnings per diluted share rising by 6% to $27.44. The company is poised for continued growth in fiscal 2025, with a focus on strategic growth pillars of oncology and biopharma services. McKesson remains committed to driving sustainable business growth, offering innovative solutions, and delivering value to its customers and stakeholders.
https://store.livarava.com/ec3165e7-0cd4-11ef-a6c2-63e1980711b2.jpg
McKesson (MCK) Reports Strong Fiscal 2024 Results and Promising Outlook for 2025

McKesson (MCK) Q4 2024 Earnings Call Transcript

Highlights:

  • Consolidated revenue grew 12% to $309 billion in fiscal 2024.
  • Adjusted earnings per diluted share rose by 6% to $27.44.
  • Fiscal 2025 outlook includes a focus on strategic growth in oncology and biopharma services.
  • McKesson aims to drive sustainable business growth and deliver value to customers and stakeholders.

McKesson's strong performance in fiscal 2024 positions the company for continued growth in fiscal 2025. With a focus on strategic growth pillars, innovative solutions, and a commitment to delivering value, McKesson remains confident in its ability to drive sustainable business growth and generate attractive shareholder returns.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe